Key indicators: single-crystal X-ray study; T = 296 K; mean (C-C) = 0.003 Å; R factor = 0.048; wR factor = 0.142; data-to-parameter ratio = 23.5.
In the asymmetric unit of the title salt [systematic name: 2,4-diamino-5-(4-chlorophenyl)-6-ethylpyrimidin-1-ium pyridine-3-sulfonate], C 12 H 14 N 4 Cl + ÁC 5 H 4 NSO 3 À , there are two independent pyrimethaminium cations and two 3-pyridine sulfonate anions. Each sulfonate group interacts with the corresponding protonated pyrimidine ring through two N-HÁ Á ÁO hydrogen bonds, forming a cyclic hydrogen-bonded bimolecular R 2 2 (8) motif. Even though the primary mode of association is the same, the next higher level of supramolecular architectures are different due to different hydrogen-bonded networks. In one of the independent molecules in the asymmetric unit, the pyrimethamine cation is paired centrosymmetrically through N-HÁ Á ÁN hydrogen bonds, generating an R 2 2 (8) ring motif. In the other molecule, the pyrimethamine cation does not form any base pairs; instead it forms hydrogen bonds with the 3-pyridine sulfonate anion. The structure is further stabilized by C-HÁ Á ÁO, C-HÁ Á ÁN and -stacking [centroid-centroid distance = 3.9465 (13) Å ] interactions.
Related literature
For background to crystal engineering and supramolecular chemistry, see: Desiraju (1989) ; Lehn (1995) . For structures involving pyrimethamine carboxylates, see ; Stanley et al. (2002) . For structures involving sulfonates, see: Hemamalini et al. (2005) ; Balasubramani et al. (2007) ; Baskar et al. (2003) . For a survey on hydrogen-bonding patterns involving sulfonate salts, see: Haynes et al. (2004) . For the crystal structures of pyrimethamine and metoprine, see: Sethuraman & Thomas Muthiah (2002) ; De et al. (1989) . For modeling studies on DHFR-PMN complexes, see: Sansom et al. (1989) . For hydrogen-bond motifs, see: Etter (1990) ; Bernstein et al. (1995) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). (Desiraju, 1989) and supramolecular chemistry (Lehn, 1995) . We have reported from our laboratory, the crystal structure of pyrimethamine (PMN), an antifolate drug used in antimalarial chemotherapy and treatment of opportunistic infections in patients with AIDS. Investigations of a fairly large number of crystal structures of pyrimethamine salts involving carboxylates Stanley et al., 2002 ) and a few sulfonates (Hemamalini et al., 2005; Balasubramani et al., 2007) have shown an inclination towards the formation of certain robust motifs and a variety of supramolecular architectures. The CSD survey by Haynes et al. (2004) on the sulfonate salts, revealed various hydrogen bonding patterns and their preferences with specific functional groups.
It is therefore of interest, to investigate the packing preferences and supramolecular architectures of the title compound (Scheme 1). The compound crystallizes in the triclinic space group P1, with two molecules in the asymmetric unit ( Figure   1 ). The crystallographically independent pyrimethamine molecules (A and B) are protonated at N1A and N1B positions as is evident from the increase in respective bond angle at C-N-C, when compared to its neutral form (Sethuraman & Thomas Muthiah, 2002) . The bond lengths and angles between the two molecules are in good agreement, with those observed in computer modeling studies on dihydrofolate reductase DHFR-PMN complexes (Sansom et al., 1989) and the crystal structure of metoprine (De et al., 1989) .
Each of the protonated pyrimethaminium (N1A and N1B) cations interacts with two oxygen atoms of the respective sulfonate anion through two N-H···O hydrogen bonds, forming an eight membered ring motif R 2 2 (8) (Etter, 1990; Bernstein et al., 1995) . It is well known that sulfonates imitate carboxylates in forming such bidentate motifs (Baskar et al., 2003) . Occurrence of such an array is a characteristic feature observed in structures reported earlier (Stanley et al., 2002) .
The pyrimethaminium cation B does not form any base pairs across its inversion related molecule, instead it forms hydrogen bonds with the 3-pyridine sulfonate(A) through N2B-H···O3A, C16A-H···N3B, N4B-H···N17A interactions to form motifs with R 2 2 (9) and R 2 2 (7) graph set notations (Figure 2 ). Combination of these motifs leads to the formation of a triplet hydrogen bond array. A previous report from our laboratory on a closely related system, pyrimethaminium benzene sulfonate salt did not yield such an array. This might be due to the absence of acceptor in the benzene ring (Balasubramani et al., 2007) .
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Other than these strong interactions, the crystal structure is stabilized by C-H···O, C-H···N interactions and π-π stacking interactions between the PMN (B) molecules, with a centroid-to-centroid distance of 3.9465 (13) Å, an interplanar spacing of 3.4332 (8) Å and a centroid offset of 1.946 Å.
From this analysis, it is evident that sulfonates, as usual has a penchant for the formation of bidentate motif and the intermolecular interactions involved in this structure paves way to the formation of two different hydrogen bonded arrays.
Identification of such patterns will help in design and construction of preferred hydrogen bonding patterns on drug like molecules.
Experimental
To obtain crystals of compound (I) suitable for X-ray study, pyrimethamine (31 mg; Shah Pharma Chemicals, India) was dissolved in hot n-propanol (20 ml) and 3-pyridine sulf77onic acid (20 mg; Merck) was dissolved in hot n-propanol (20 ml). The two solutions were mixed and warmed for 20 minutes over a water bath. The solution was allowed to evaporate slowly. After a few days, colourless crystals were obtained.
Refinement
All the hydrogen atoms were positioned geometrically and were refined using riding model. The N-H and C-H bond lengths are 0.86 and 0.93 Å, respectively [U iso (H) = 1.2U eq (parent atom)]. (9) −0.0157 (9) −0.0069 (7) 0.0051 (7) supplementary materials sup-13 
